Literature DB >> 16009831

Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7.

Hans E Grossniklaus1, Päivi H Miskala, W Richard Green, Susan B Bressler, Barbara S Hawkins, Cynthia Toth, David J Wilson, Neil M Bressler.   

Abstract

OBJECTIVES: To identify the histologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions from patients enrolled in the Submacular Surgery Trials and to compare them with clinical data.
METHODS: Surgically excised subfoveal choroidal neovascular lesions from patients enrolled in the Submacular Surgery Trials group N trial (lesion predominantly choroidal neovascularization [CNV] with evidence of classic CNV from age-related macular degeneration), group B trial (lesion predominantly hemorrhagic from age-related macular degeneration), and group H trial (idiopathic subfoveal CNV or subfoveal CNV from ocular histoplasmosis syndrome) between October 1, 1999, and September 1, 2001, were submitted to the pathology center. The lesion growth pattern (subretinal pigment epithelial [sub-RPE], subretinal, combined, or indeterminate) and the cellular and extracellular constituents were classified independently. Demographic, clinical, and fluorescein angiographic characteristics of patients, eyes, and lesions, respectively, were compared with the pathologic features.
RESULTS: Of 269 patients assigned to surgery during the 24 months that pathologic specimens were collected, surgical specimens from study eyes of 199 were submitted to the pathology center. Of the 199 routine histologic specimens processed, 144 (72%) were classified as CNV, 51 (26%) as fibrocellular tissue, and 4 (2%) as hemorrhage. The median specimen size was smaller in group H (932 x 208 mum) than in groups N (1980 x 325 mum) and B (1800 x 395 mum). The CNV growth pattern was determined in 91 (46%) of 199 specimens. Of 159 group N and group B lesions, 76 (48%) had an indeterminate growth pattern, 28 (18%) had a sub-RPE growth pattern, and 33 (21%) had sub-RPE and subretinal growth patterns. Of 40 group H lesions, 32 (80%) had an indeterminate growth pattern, 7 (18%) had a subretinal growth pattern, and 1 (2%) had a combined sub-RPE and subretinal pattern. Based on electron microscopy, the most common cellular lesion components were RPE, macrophages, erythrocytes, fibrocytes, and vascular endothelium; the most common extracellular components were 24-nm collagen and fibrin. Basal laminar and linear deposits were found in 80% (40/50) and 16% (8/49) of group N specimens, 66% (43/65) and 5% (3/65) of group B specimens, and 8% (2/26) and 0% (0/26) of group H specimens, respectively.
CONCLUSIONS: Most surgically excised subfoveal specimens had evidence of CNV or tissue associated with CNV. The constituents in CNV were consistent with granulation tissue proliferation. The presence of basal deposits in surgically excised specimens suggested a clinical diagnosis of age-related macular degeneration, even when blood was the predominant component of the lesion. Correlation of growth patterns above or below the RPE with fluorescein angiographic patterns of classic or occult CNV was limited because most specimens had insufficient material to determine these patterns.

Entities:  

Mesh:

Year:  2005        PMID: 16009831     DOI: 10.1001/archopht.123.7.914

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  40 in total

1.  Imaging polarimetry in patients with neovascular age-related macular degeneration.

Authors:  Ann E Elsner; Anke Weber; Michael C Cheney; Dean A VanNasdale; Masahiro Miura
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

Review 2.  Age-related macular degeneration and the immune response: implications for therapy.

Authors:  Robert B Nussenblatt; Frederick Ferris
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

Review 3.  Doyne lecture 2016: intraocular health and the many faces of inflammation.

Authors:  A D Dick
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

Review 4.  Inflammatory Mechanisms of Age-related Macular Degeneration.

Authors:  Jared E Knickelbein; Chi-Chao Chan; H Nida Sen; Frederick L Ferris; Robert B Nussenblatt
Journal:  Int Ophthalmol Clin       Date:  2015

5.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

Review 6.  Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration.

Authors:  Chi-Chao Chan; Daniel Ardeljan
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Inflammatory Cytokines Induce Expression of Chemokines by Human Retinal Cells: Role in Chemokine Receptor Mediated Age-related Macular Degeneration.

Authors:  Chandrasekharam N Nagineni; Vijay K Kommineni; Nader Ganjbaksh; Krishnasai K Nagineni; John J Hooks; Barbara Detrick
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

8.  CCR3 is a target for age-related macular degeneration diagnosis and therapy.

Authors:  Atsunobu Takeda; Judit Z Baffi; Mark E Kleinman; Won Gil Cho; Miho Nozaki; Kiyoshi Yamada; Hiroki Kaneko; Romulo J C Albuquerque; Sami Dridi; Kuniharu Saito; Brian J Raisler; Steven J Budd; Pete Geisen; Ariel Munitz; Balamurali K Ambati; Martha G Green; Tatsuro Ishibashi; John D Wright; Alison A Humbles; Craig J Gerard; Yuichiro Ogura; Yuzhen Pan; Justine R Smith; Salvatore Grisanti; M Elizabeth Hartnett; Marc E Rothenberg; Jayakrishna Ambati
Journal:  Nature       Date:  2009-06-14       Impact factor: 49.962

9.  Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration.

Authors:  Mihoko Suzuki; Motohiro Kamei; Hiroyuki Itabe; Kazuhito Yoneda; Hajime Bando; Noriaki Kume; Yasuo Tano
Journal:  Mol Vis       Date:  2007-05-23       Impact factor: 2.367

10.  Autologous translocation of choroid and retinal pigment epithelium in geographic atrophy: long-term functional and anatomical outcome.

Authors:  Albert Caramoy; Sandra Liakopoulos; Erica Menrath; Bernd Kirchhof
Journal:  Br J Ophthalmol       Date:  2009-08-18       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.